Association of SDOH with mortality without transplant
Variable . | Hazard ratio . | 95% CI . | P value . | Global P value . |
---|---|---|---|---|
Median income | 0.89 | 0.78-1.02 | .101 | |
Proportion with less than a high school education | 1.21 | 0.99-1.46 | .058 | |
Proportion below federal poverty level | 1.16 | 0.96-1.39 | .119 | |
Proportion on SNAP | 1.13 | 0.97-1.31 | .105 | |
Proportion spending ≥30% of their income on housing | 0.99 | 0.82-1.19 | .889 | |
Proportion with a second mortgage or a home equity loan | 0.93 | 0.73-1.18 | .538 | |
Proportion on SSI | 1.41 | 1.01-1.97 | .045 | |
Proportion driving to work alone | 1.10 | 0.98-1.24 | .114 | |
Race | ||||
White | 1 | --- | .051 | |
Asian | 0.62 | 0.27-1.43 | ||
Black | 0.59 | 0.36-0.97 | ||
Other | 1.38 | 0.84-2.27 | ||
Race∗ | ||||
White | 1 | --- | .024 | |
Asian | 0.59 | 0.26-1.33 | ||
Black | 1.11 | 0.69-1.76 | ||
Other | 1.92 | 1.20-3.06 |
Variable . | Hazard ratio . | 95% CI . | P value . | Global P value . |
---|---|---|---|---|
Median income | 0.89 | 0.78-1.02 | .101 | |
Proportion with less than a high school education | 1.21 | 0.99-1.46 | .058 | |
Proportion below federal poverty level | 1.16 | 0.96-1.39 | .119 | |
Proportion on SNAP | 1.13 | 0.97-1.31 | .105 | |
Proportion spending ≥30% of their income on housing | 0.99 | 0.82-1.19 | .889 | |
Proportion with a second mortgage or a home equity loan | 0.93 | 0.73-1.18 | .538 | |
Proportion on SSI | 1.41 | 1.01-1.97 | .045 | |
Proportion driving to work alone | 1.10 | 0.98-1.24 | .114 | |
Race | ||||
White | 1 | --- | .051 | |
Asian | 0.62 | 0.27-1.43 | ||
Black | 0.59 | 0.36-0.97 | ||
Other | 1.38 | 0.84-2.27 | ||
Race∗ | ||||
White | 1 | --- | .024 | |
Asian | 0.59 | 0.26-1.33 | ||
Black | 1.11 | 0.69-1.76 | ||
Other | 1.92 | 1.20-3.06 |
Each row represents 1 model for 1 SDOH variable adjusted for age and HCT-CI; each as a continuous linear variable; Karnofsky performance status, Patient Health Questionnaire 9 scale for depression, activities of daily living scale, 4-meter walk speed, quality of life per Functional Assessment of Cancer Treatment; each as continuous linear time-varying covariates; and diagnosis type, ELN risk, intensity of induction therapy.
Unadjusted model (univariate analysis).